Company: HCTI
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-076686
Chunk: 7

Company: Healthcare Triangle, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 7
---
. In the opinion of management, the accompanying unaudited
condensed consolidated financial statements contain all adjustments, consisting of items of a normal and recurring nature, necessary
to present fairly our financial position as of June 30, 2025, the results of operations, comprehensive loss, stockholders’ deficit,
and cash flows for the six months ended June 30, 2025 and 2024. The results of operations for the six months ended June 30, 2025 and
2024 are not necessarily indicative of the results to be expected for the full year. The information contained herein should be read
in conjunction with the audited financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2024
filed with the SEC. Management considers events or transactions that occur after the balance sheet date but before the financial statements
are issued to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. Subsequent
events have been evaluated through the date of issuance of these financial statements.

6

HEALTHCARE TRIANGLE, INC.

Notes To Condensed Consolidated Financial Statements

(Unaudited)

(In thousands except share and per share data)

Use of Estimates

The preparation of financial statements is in
conformity with GAAP which requires us to make estimates, judgments and assumptions that affect the financial statements and the notes
thereto. These estimates are based on information available as of the date of the financial statements. On a regular basis, management
evaluates these estimates and assumptions. Items subject to such estimates and assumptions include, but are not limited to:

    ●
    the standalone selling price for each distinct performance obligation;

    ●
    the fair value of assets acquired, and liabilities assumed for business combinations;

●the expected credit loss relating to accounts receivable;

●the determination of contingent consideration amount; and 

    ● share based compensation including warrants. 

Emerging Growth Company Status

We are an “emerging growth company,”
as defined in the Jumpstart Our Business Startups Act of 2012. We will remain an emerging growth company until the earlier of (i) December
21, 2026 (the last day of the fiscal year following the fifth anniversary of our IPO), (ii) the last day of the first fiscal year in
which we have total annual gross revenue of at least $1.07 billion, (iii) the last day of the first fiscal year in which we are deemed